Shenandoah Therapeutics

South San Francisco, United States

Shenandoah Therapeutics is a biotechnology company.

$20.0M raised

Jun 2025

Seed

Health Care Medical Personal Health

Top Investors

Highlight Capital Samsara BioCapital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Shenandoah Therapeutics

How much funding has Shenandoah Therapeutics raised?

Shenandoah Therapeutics has raised $20.0M in total funding. The most recent round was Seed. The last funding was announced in June 2025.

Who are Shenandoah Therapeutics's investors?

Shenandoah Therapeutics's investors include Highlight Capital, Samsara BioCapital.

Where is Shenandoah Therapeutics headquartered?

Shenandoah Therapeutics is headquartered in South San Francisco, United States.

What does Shenandoah Therapeutics do?

Shenandoah Therapeutics is a biotechnology company.

What stage is Shenandoah Therapeutics at?

Shenandoah Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 19, 2025.

MLA

"Shenandoah Therapeutics — Funding & Investors." VCBacked, June 19, 2025, https://www.vcbacked.co/company/shenandoah-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Shenandoah Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/shenandoah-therapeutics

Wikipedia (cite web)

{{cite web |title=Shenandoah Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/shenandoah-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 19, 2025.